Gordon Carl L's Form 4 filing
Theseus Pharmaceuticals, Inc. (THRX) · filed Jan 21, 2022
- Accession no.
- 0000947871-22-000088
- Filed
- Jan 21, 2022
- Trade date
- Jan 19-21, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $1.58M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gordon Carl LCIK 0001282930 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2022 | Common Stock | PPurchaseAcquired | +11,521 | $9.97F1 | +$114,864.37 | 16,395,756 | Indirect | |
| Jan 20, 2022 | Common Stock | PPurchaseAcquired | +35,000 | $9.95F3 | +$348,250 | 16,430,756 | Indirect | |
| Jan 21, 2022 | Common Stock | PPurchaseAcquired | +111,896 | $9.97F4 | +$1,115,603.12 | 16,542,652 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares of the Issuer's common stock ("Shares") were purchased in a block order at price of $9.97.
Referenced by the price of 1 transaction in Table I.
- F3
These Shares were purchased in a block order at price of $9.95.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average purchase price of the Shares purchased ranging from a low of $9.495 to a high of $10.275 per Share. The Reporting Person undertakes, upon request by the Commission staff, the Issuer or a security holder of the Issuer, to provide full information regarding the number of Shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.